for me, the trial start is a home run. maybe for the market, given that we won't know anything for a couple months, it's a yawner - who knows? but i think we get the news we need in a couple months.

the thing from the call that jumped out a bit was the CRO issue. sounds like we're looking for a new one, but haven't hired one?

anyone know how long that type of thing should take? Is it safe to say the BLA process isn't going to accelerate until that's completed? NP seems to punt the BLA question near the end of the call - focusing on Brazil instead. Don't know if anyone else got that sense?